Name | N-Methylnicotinamide |
Synonyms | SOT-1-IMF Methylnicotinamide N-Methylnicotinamide N-METHYLNICOTINAMIDE N'-METHYLNICOTINAMIDE METHYLNICOTINAMIDE, N- N-methylpyridine-3-carboxamide N-Methyl-3-pyridinecarboxamide. 3-Pyridinecarboxamide, N-methyl- 3-Pyridinecarboxamide,N-methyl-(9CI) |
CAS | 114-33-0 |
EINECS | 204-046-4 |
InChI | InChI=1/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10) |
Molecular Formula | C7H8N2O |
Molar Mass | 136.15 |
Density | 1.1778 (rough estimate) |
Melting Point | 102-105°C(lit.) |
Boling Point | 250.42°C (rough estimate) |
Flash Point | 164.1°C |
Solubility | Soluble in water (18.6 g/l). |
Vapor Presure | 5.3E-05mmHg at 25°C |
Appearance | White to pale yellow-beige crystalline powder |
Color | White to Off-White |
pKa | 13.97±0.46(Predicted) |
Storage Condition | Inert atmosphere,Room Temperature |
Refractive Index | 1.5769 (estimate) |
MDL | MFCD00006384 |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
biological activity | N-Methylnicotinamide (MNA, Nicotinyl Methylamide, N-Methyl-3-pyridinecarboxamide) is an active endogenous metabolite that can improve endothelial dysfunction and reduce atherosclerosis by regulating the ADMA-DDAH axis. |